| HOME >> BIOLOGY >> TECHNOLOGY |
-Tables Follow-
TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2009 AND 2008
(Unaudited)
Three months ended Six months ended
June 30, June 30,
2009 2008 2009 2008
REVENUE - RELATED PARTIES $20,551,036 $19,654,447 $38,788,581 $32,475,268
COST OF SALES - RELATED
PARTIES 6,117,409 6,203,705 11,852,468 10,243,765
GROSS PROFIT 14,433,627 13,450,742 26,936,113 22,231,503
SELLING, GENERAL AND
ADMINISTRATIVE EXPENSES 4,014,591 5,088,597 7,145,527 8,335,796
INCOME FROM OPERATIONS 10,419,036 8,362,145 19,790,586 13,895,707
Interest expense (53,201) (80,078) (105,817) (132,662)
Interest income 100,779 268,517 186,547 505,849
Other (expense) (28,144) (1,246,287) (73,432) (986,864)
OTHER (EXPENSE) INCOME,
NET 19,434 (1,057,848) 7,298 (613,677)
INCOME BEFORE INCOME TAXES 10,438,470 7,304,297 19,797,884 13,282,030
INCOME TAXES 123,101 1,664,054 482,716 3,144,448
NET INCOME 10,315,369 5,640,243 19,315,168 10,137,582
LESS: Net income
attributable to the
noncontrolling
interest (139,071) (998,642) (546,045) (1,887,079)
NET INCOME ATTRIBUTABLE
TO THE COMPANY 10,176,298 4,641,601 18,769,123 8,250,503
'/>"/>
| SOURCE Tiens Biotech Group ( Copyright©2009 PR Newswire. All rights reserved |